VFA
AVEO

Virtus Fund Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Virtus Fund Advisers’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$337K Buy
+12,065
New +$375K ﹤0.01% 427

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Virtus Fund Advisers's AVEO Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2017: 12,065 shares worth $337K. The stake represents ﹤0.01% of the portfolio and ranks #427 among its holdings.

84 funds tracked by Wall St. Rank hold AVEO as of Q4 2017.

  • Virtus Fund Advisers held 12,065 shares of AVEO Pharmaceuticals, Inc. worth $337K as of Q4 2017.
  • AVEO Pharmaceuticals, Inc. was a new Virtus Fund Advisers position in Q4 2017.
  • AVEO Pharmaceuticals, Inc. made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #427 holding.
  • 84 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.